| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 77581 |
DOTAP chloride CAS:132172-61-3 |
89 |
h |
2024-12-17 |
| 77582 |
EZ-Link烷氧基胺-peg 4-SS-peg 4-生物素亲，烷基链定制 |
116 |
wyh |
2024-12-17 |
| 77583 |
SSTR拮抗剂DOTA-LM3 TFA |
106 |
h |
2024-12-17 |
| 77584 |
cas:2028284-73-1，Tos-PEG5-CH2CO2H，对甲苯磺酸酯-四聚乙二醇-乙酸 |
68 |
kx |
2024-12-17 |
| 77585 |
两亲性二嵌段共聚物MPEG44-b-Phe，烷基链定制 |
110 |
wyh |
2024-12-17 |
| 77586 |
DOTATATE CAS:177943-88-3 |
92 |
h |
2024-12-17 |
| 77587 |
18F-AlF/177Lu-NOTA-Gly3-E(2PEG4-RGD-WH701)探针-定制 |
105 |
zyl |
2024-12-17 |
| 77588 |
4-Aminobutyl-DOTA CAS:753421-63-5 |
75 |
h |
2024-12-17 |
| 77589 |
cas:2143097-05-4，Pomalidomide-PEG2-CH2COOH，小分子peg |
76 |
kx |
2024-12-17 |
| 77590 |
mPEG(113)-b-P(MTC-Chol)(4)，烷基链定制 |
108 |
wyh |
2024-12-17 |
| 77591 |
DOTA-Leu-Gly-Glu-Tyr-Gly-Phe-Gln-Asn-Ala-Leu-Ile-V |
107 |
h |
2024-12-17 |
| 77592 |
PEG114-b-P4VP107， 聚乙二醇-b-聚(4-乙烯基吡啶)，烷基链定制 |
113 |
wyh |
2024-12-17 |
| 77593 |
NH2-PEG4-DOTA-GA,CAS：137076-54-1 |
88 |
h |
2024-12-17 |
| 77594 |
99mTc-HYNIC-lys(Cy5.5)-PEG4-biotin 新型双模态探针 |
129 |
zyl |
2024-12-17 |
| 77595 |
cas:448954-98-1，HBr.H2N-O-(CH2)5-COOH， 6-氨基氧基己酸氢溴酸盐 |
91 |
kx |
2024-12-17 |
| 77596 |
马来酰亚胺修饰的大环配体Maleimide-DTPA |
98 |
h |
2024-12-17 |
| 77597 |
DOTA-3-酪氨酰基-奥曲肽,177943-89-4 |
71 |
h |
2024-12-17 |
| 77598 |
mPEG5-NHMe的介绍 |
95 |
zyl |
2024-12-17 |
| 77599 |
过表达质粒转染的原理和步骤 |
846 |
axc |
2024-12-17 |
| 77600 |
二聚体荧光探针(TMTP1-PEG4)2-ICG-定制 |
112 |
zyl |
2024-12-17 |
| 77601 |
DOTA-cyclo(RGDfK)acetate,909024-55-1 |
95 |
h |
2024-12-17 |
| 77602 |
MAG3-PEG8-c(RGDYK)，烷基链定制 |
120 |
wyh |
2024-12-17 |
| 77603 |
mPEG113-b-P(MTC-Chol11)-定制 |
87 |
zyl |
2024-12-17 |
| 77604 |
DOTA-Peptide C105Y;DOTA偶联Peptide C105Y |
88 |
h |
2024-12-17 |
| 77605 |
靶向Nectin-4的抗体药物偶联物，烷基链定制 |
160 |
wyh |
2024-12-17 |
| 77606 |
DOTA-RGD-4C,DOTA偶联RGD-4C |
87 |
h |
2024-12-17 |
| 77607 |
靶向EGFR的抗体药物偶联物(EGFR-ADC)-定制 |
127 |
zyl |
2024-12-17 |
| 77608 |
DOTA-MAP;DOTA偶联细胞穿膜肽MAP |
88 |
h |
2024-12-17 |
| 77609 |
DOTA偶联PH响应性细胞穿膜肽TH |
108 |
h |
2024-12-17 |
| 77610 |
抗体药物偶联物的药物-连接子MC-MMAF-定制服务 |
131 |
zyl |
2024-12-17 |
| 77611 |
抗cMet抗体药物偶联物，烷基链定制 |
150 |
wyh |
2024-12-17 |
| 77612 |
DOTA-PT;大环配体-PT多肽 |
97 |
h |
2024-12-17 |
| 77613 |
MC-VC-PAB-PNP，ADC肽类连接子，烷基链定制 |
190 |
wyh |
2024-12-17 |
| 77614 |
DOTA-(D-Gln)3-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
100 |
h |
2024-12-17 |
| 77615 |
DOTA-SP0104;大环配体-SP0104多肽 |
152 |
h |
2024-12-17 |
| 77616 |
MC-Val-Cit-PAB-DOX，Doxorubicin-MVCP，烷基链定制 |
134 |
wyh |
2024-12-17 |
| 77617 |
DOTA-三叔丁酯活性酯,DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
165 |
h |
2024-12-17 |
| 77618 |
DOTA-(COOt-Bu)3-butyne,丁炔-DOTA-三(叔丁基酯) |
139 |
h |
2024-12-17 |
| 77619 |
MC-Val-Cit-PAB，抗体-药物缀合物，烷基链定制 |
91 |
wyh |
2024-12-17 |
| 77620 |
RNA干扰实现基因敲减，技术详情 |
209 |
axc |
2024-12-17 |
| 77621 |
FolA-PEG24-K(Stp4-C)2，烷基链定制 |
84 |
wyh |
2024-12-17 |
| 77622 |
Fab-PEG(24)-EGF， 曲妥珠单抗聚乙二醇偶联表皮生长因子，烷基链定制 |
155 |
wyh |
2024-12-17 |
| 77623 |
DOTA-TOC,DOTA-[Tyr3]-Octreotide,Edotreotide |
109 |
h |
2024-12-17 |
| 77624 |
聚吡咯-聚乙二醇24 PPY-PEG24，烷基链定制 |
108 |
wyh |
2024-12-17 |
| 77625 |
双功能螯合剂THP(Bz)3-NH2,CAS：827331-42-0 |
134 |
h |
2024-12-17 |
齐岳微信公众号
官方微信
库存查询